Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.
作者:
主题词
碱基序列(Base Sequence);溴脱氧尿苷(Bromodeoxyuridine);细胞分裂(Cell Division);细胞系(Cell Line);细胞存活(Cell Survival);环加氧酶抑制药(Cyclooxygenase Inhibitors);DNA引物(DNA Primers);地诺前列酮(Dinoprostone);人类(Humans);口腔黏膜(Mouth Mucosa);口腔肿瘤(Mouth Neoplasms);吡罗昔康(Piroxicam);聚合酶链反应(Polymerase Chain Reaction);癌前状态(Precancerous Conditions);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1002/ijc.11499
PMID
14566835
发布时间
2016-03-03
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文